Finance

Beta
Lists
4574:TYO
TAIKO PHARMACEUTICAL CO LTD
¥252.00
+1.20%
(+3.00) 1D
Jun 3, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4574...
Open
¥250
High
¥253
Low
¥246
Mkt. cap
12.76B
Avg. vol.
102.56K
Volume
122.70K
P/E ratio
23.63
52-wk high
¥444
52-wk low
¥239
EPS
¥11
Shares outstanding
14.34M
No. of employees
220
Open
¥250
High
¥253
Low
¥246
Mkt. cap
12.76B
Avg. vol.
102.56K
Volume
122.70K
P/E ratio
23.63
52-wk high
¥444
52-wk low
¥239
EPS
¥11
Shares outstanding
14.34M
No. of employees
220
News stories
From sources across the web
About TAIKO PHARMACEUTICAL CO LTD
CEO-
Employees220
FoundedNov 18, 1946
Headquarters-
SectorMedical device
Websiteseirogan.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.26B
1.82B
2.17B
916.00M
Cost of goods sold
620.00M
777.00M
1.05B
415.00M
Cost of revenue
620.00M
777.00M
1.05B
415.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
639.00M
763.00M
986.00M
598.00M
Operating expense
639.00M
763.00M
986.00M
598.00M
Total operating expenses
1.26B
1.54B
2.03B
1.01B
Operating income
3.00M
277.00M
134.00M
-97.00M
Other non operating income
3.00M
1.00M
16.00M
-3.00M
EBT including unusual items
13.00M
439.00M
137.00M
-95.00M
EBT excluding unusual items
9.00M
434.00M
29.00M
-95.00M
Income tax expense
26.00M
49.00M
-117.00M
-
Effective tax rate
200.00%
11.16%
-85.40%
-
Other operating expenses
-
-
-
-
Net income
-13.00M
390.00M
254.00M
-95.00M
Net profit margin
-1.03%
21.46%
11.72%
-10.37%
Earnings per share
-
-
-
-
Interest and investment income
3.00M
6.00M
3.00M
9.00M
Interest expense
-2.00M
-1.00M
-1.00M
-
Net interest expenses
1.00M
5.00M
2.00M
9.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
65.50M
341.00M
200.25M
-30.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer